Background: Home parenteral nutrition (HPN) is a life-sustaining therapy for short bowel syndrome (SBS) and other severe digestive diseases, but complications are common. We evaluated a predischarge HPN hands-on training course to reduce complications in children with SBS, including hospital readmissions. Methods: We conducted a prospective, nonrandomized controlled research study between April 1, 2014, and April 30, 2017. Eligible participants were children aged <18 years old with SBS and anticipated HPN dependence duration ࣙ6 months. Excluded participants had a previous history of discharge with a central venous catheter (CVC), HPN, or intravenous fluids or strictly palliative goals of care. An intervention group practiced hands-on HPN within the hospital room for 24 hours using infusion equipment. The groups received standard teaching (CVC care, home infusion pump operation, HPN preparation and administration). Results: Nine children were assigned to the intervention group and 12 served as controls. The median age was 8.4 months, and length of stay (LOS) was 82 days. All participants experienced ࣙ1 event, with a total of 47 issues related to HPN. There were no significant associations between group assignment and 30-day postdischarge events. Each additional week of LOS was associated with 11% increase in the odds of an emergency department visit (OR 1.11; 95% CI, 1.01-1.26) and 16% increase in the odds of readmission (OR 1.16; 95% CI, 1.04-1.37). Conclusions: Postdischarge events remained widespread despite HPN bedside interventions offered by this pilot intervention. With refinement of HPN discharge processes, quality benchmarks are needed. (JPEN J Parenter Enteral Nutr. 2018;42:1295-1303 
Introduction
Reductions of readmissions and postdischarge complications are increasingly looked upon as a quality metrics for all healthcare centers. Nearly 30% of pediatric hospital readmissions are potentially preventable. 1 Pediatric 30-day readmissions are tracked in a variety of complex conditions, including lower respiratory infections, sickle cell disease, and appendicitis. [2] [3] [4] Readmissions are commonly associated with complex therapies, not only conditions. Home parenteral nutrition (HPN) is a life-sustaining, complex therapy for children and adults with short bowel syndrome (SBS) and other severe digestive diseases. 5 SBS results from intestinal malabsorption related to massive surgical bowel resection. 6 HPN provides for daily nutrition requirements not met by enteral nutrition (EN) including hydration, electrolytes, protein, lipids, vitamins, and minerals. Even children with ultra-SBS, defined as residual bowel length approximately 20 cm, can achieve good treatment outcomes. [7] [8] [9] Increasingly, patients are receiving this therapy because it is recognized as the best option over prolonged hospitalization for improving quality of life. Between 25,000-40,000 children and adults receive HPN in the United States. 10, 11 Patients discharged on HPN represent a particularly high-risk group for readmissions. Vallabh et al 12 reported that the 30-day unplanned readmission rate was 32% in an adult HPN cohort.
Many healthcare resources are dedicated to preparing families for successful discharge on HPN. Caregivers receive extensive teaching on a variety of topics, including maintaining safe medical environment, hand hygiene, central venous catheter (CVC) care, HPN preparation, infusion pump usage, infection control, and troubleshooting common issues. In 2013, along with Dana-Farber/Boston Children's Cancer and Blood Disorders Center, we published a webbased video series to teach CVC care for caregivers and families based on family and staff feedback that bedside teaching was inadequate and inconsistent. 13 HPN nurses, floor nursing, and home infusion nursing as well as visiting nursing provide hands-on teaching as well. There is limited literature on successful interventions to improve discharge transitions for pediatric HPN patients.
The objective of this pilot study was to examine the impact of a hands-on, 24-hour HPN experience for families on 30-day readmissions and postdischarge events as well as parent perceptions of readiness for discharge, the quality of discharge teaching, and coping ability.
Methods

Study Participants
Patients and families were eligible for the study if they were discharged home from the Boston Children's Hospital for the first time and followed by the our HPN program between April 1, 2014-April 30, 2017. Our interdisciplinary HPN program includes pediatric nurses, nurse practitioners, registered dietitians, clinical pharmacists, and gastroenterologists and is designed to provide care to all patients discharged from the hospital who require HPN or intravenous (IV) fluid support. Patients were included in the study if they met the following characteristics: SBS (as defined by intestinal resection for acquired or congenital gastrointestinal diseases, leading to clinically significant malabsorption and requiring specialized nutrition therapy) 14 ; age younger than 18 years; parent or other adult caregiver identified to receive HPN teaching; anticipated discharge with standard HPN solution and infusion supplies; and anticipated duration of HPN therapy for at least 6 months. Patients were excluded from the study if they had previous history of discharge home with a CVC, HPN, or IV fluids or had strictly palliative goals of care. The hospital institutional review board approved the protocol (IRB-P00015165).
Study Design
This pilot trial was a prospective, nonrandomized controlled research study. Participants and medical teams in both cohorts were aware of their assignments. Figure 1 depicts the HPN discharge process including inpatient and outpatient steps. A convenience sample of 20 patients was chosen. During the study period, 67 patients were assessed for eligibility. A total of 46 patients were excluded, including 45 who did not meet inclusion criteria and 1 family who declined participation (consort diagram available in the Supporting Information). The remaining 21 patients were allocated between the 2 arms of the study according to a predetermined order. Study enrollment ceased when grant funding ended.
The observation and intervention groups received the same standardized HPN discharge didactic teaching. All families regardless of study arm received hands-on training in the hospital on operating a home infusion pump. All families regardless of study arm discharged with EN received standardized teaching from nursing and nutrition. All families allocated to the intervention group also participated in a hands-on HPN care within hospital room for 24 hours using study-supplied home equipment. Supplies provided to the intervention group to use included the Curlin PN infusion pump (ZEVEX, Salt Lake City, UT), infusion tubing and supplies, plastic organizer bin, alcoholbased hand sanitizer, liquid soap, and paper towels as well as an aluminum cookie sheet as a clean work surface for preparing HPN. A home infusion company nurse supported the family at the patient's bedside until the HPN infusion was fully setup to fully simulate a home experience. The home infusion company nurse was not present during the entire cycled PN infusion, which is the standard of care for the community. Intervention families received instructions to act independently with CVC care as they would on discharge, without nursing care from the floor nurses. Families were expected to prepare the HPN bag (add IV multivitamins and spike the HPN bag with IV tubing) and to administer HPN overnight. Families monitored the patient for issues with infusions and would attempt to troubleshoot if needed. At the end of the HPN infusion, the families were asked to disconnect the tubing and provide proper CVC care. In contrast, the controls used actual home HPN equipment for the first time only following discharge, not in the hospital prior to discharge, per standard practice. Control patients received standard bedside nursing care up until hospital discharge. Within a week after each participant's intervention, we collected anonymous feedback from all participating staff using an online survey via SurveyMonkey. 15 The study team incorporated the feedback into rapid-cycle design improvements, such as predischarge briefings, updated standard HPN supplies lists, revised staff manuals, and situation background assessment recommendation communications to on-call staff.
One member of each family was asked to complete 3 validated surveys using Likert-type questionnaires at designated time periods in both groups. The Readiness for Hospital Discharge Survey (RHDS) is a 29-item tool used to assess parents' perception of readiness for discharge, which was completed within 24 hours prior to discharge. 16 The Quality of Discharge Teaching Scale (QDTS) measures teaching content, such as care of child at home, information about medical care, knowledge about when/how to call provider, and parent's feelings as well as delivery, such as skill of nurses in providing education to parent. 17 The Postdischarge Coping Difficulty Scale (PDCDS) is an 18-item tool used to measure the degree of parental difficulty in coping with stress, recovery, family self-management, support, confidence, and child's adjustment after hospital discharge. 17 The QDTS and PDCDS were completed at their outpatient HPN follow-up visit, which was typically 1-4 weeks postdischarge. At 30 days postdischarge, families completed an anonymous, open-ended, single-question online survey via REDCap. 18 For 30 days postdischarge, events were collected via review of electronic medical record review, including emergency department (ED) visits, all-cause readmission, central-line-associated bloodstream infection (CLABSI), and HPN and non-HPN-related events. We conducted a medical chart review to record the following parent and child characteristics: parent age, patient age at discharge, gender, gestational age, stoma presence, residual small bowel length, previous hospital-acquired CLABSI, ethnicity, distance between the hospital and home, insurance type, presence of home nursing care, diagnosis, hospital unit, number of HPN teaching sessions, and length of stay (LOS).
Analysis Approach
Descriptive statistics were used to compare demographic characteristics between the intervention and control groups. Frequencies and percentages were calculated for count variables, medians and interquartile ranges for continuous variables. To account for a small sample size, we used Fisher's exact test to compare demographic characteristics between the intervention and control groups. The Mann-Whitney U test was used to compare nonnormally distributed variables between the 2 groups.
Univariate logistic and linear regressions were used to analyze relationships between the outcomes of interest (ED visits, readmission, and scores from RHDS, QDTS, and PD-CDS) and the demographic characteristics in Table 1 . Univariate relationships significant at P < .10 were considered collectively in multivariate models in Table 2 . The χ 2 test was used to compare the proportion of new HPN patients who experienced readmissions before vs after interventions. All tests of significance were 2-sided, and comparisons at P < .05 were considered statistically significant. Statistical analyses were performed using STATA SE14 (StataCorp LP, College Station, TX). Figure 2 shows the research study enrollment. We enrolled a total of 21 patients with SBS who were initially discharged on HPN, including 9 participants in the intervention group. Participant demographics are listed in Table 3 . The gestational age at birth was 33 (29-35) weeks. The residual small bowel length was 37 (27-55) cm with 4/21 (19%) having ultra-SBS and 9 (43%) having a stoma at discharge. Nine (43%) have a previous hospital-acquired CLABSI. The intervention and control groups were similar in all characteristics, except for the number of teaching sessions.
Results
All families in the intervention group independently performed CVC care and administered HPN overnight. Table 4 shows a comparison of the 2 groups according to the 3 discharge surveys. There were no significant differences between the 2 groups in terms of the RHDS or QDTS. There was a nonstatistically different trend toward higher PDCDS scores in the intervention group when compared with the control group.
Postdischarge events are described in Table 5 . Readmission rates were similar in both groups. There were 3 hospitalizations affecting 3 patients in the control group, and 7 hospitalizations affecting 5 patients in the intervention group. Also, there were a similar number of outpatient visits with nearly all patients completing a follow-up visit. All participants experienced at least 1 complication related to HPN. There were a similar number of ED visits in both groups. In the control group, there were 5 ED visits affecting 4 patients, whereas in the intervention group there were 8 ED visits affecting 6 patients. There was 1 CLABSI in the intervention group, and none in the control group. All of the participants regardless of group participation experienced vomiting and diarrhea requiring medical attention. None of the participants discontinued HPN during the study period.
There was no association observed between any of the 3 surveys mean scores and odds of ED visit, readmissions, and CLABSI. Each additional week of initial LOS was associated with an 11% increase in the odds of an ED visit (OR 1.11; 95% CI: 1.01, 1.26), and a 16% increase in the odds of readmission (OR 1.16; 95% CI: 1.04, 1.37). Mean RHDS score in whites was 1.16 points lower than in nonwhites (95% CI: −2.12, −0.20; P = .02). When compared with the patients with necrotizing enterocolitis, mean RHDS score was 2.12 points lower in patients with intestinal atresia (95% CI: −3.52, −0.71; P = .007), 1.87 points lower in patients with Hirschsprung's disease (95% CI: −3.19, −0.38; P = .02), and 3.55 points lower in patients with omphalocele (95% CI: −5.37, −1.73; P = .001). When adjusted for insurance, the differences in mean RHDS score among the diagnoses and ethnic groups were not significant. Figure 2 depicts the program-wide percentage of patients readmitted within 30 days after initial discharge on HPN from October 2012-June 2017. Following publication of the web-based video series titled Caring for a Central Line at Home, there was a statistically significant decrease in readmissions from 60%-28% (P = .004). There was a nonsignificant rise in readmissions following the launch of the hands-on intervention when compared with the previous period (P = .55).
Discussion
This was a prospective, controlled study involving children with SBS initially discharged on HPN. As we demonstrated in this study, our program reduced readmissions programwide by standardizing CVC teaching with the development of a web-based video series titled Caring for a Central line at Home. We were interested in studying whether an effort to standardize the HPN discharge process might reduce readmissions. In the present study, we found that all 21 patients in our sample experienced at least 1 adverse event within 30 days of discharge, with 47 issues related to HPN. In this cohort, approximately 30% of the patients were readmitted, which is similar to what has been reported in adults. 12 Despite similar stress of caring for a family member with a severe digestive disorder, discharge outcomes might be expected to be worse for children when compared with adults. CVC care in children can be particularly challenging due to small physical size and poor patient cooperation.
Children receiving HPN have higher readmission rates than many of the most complex pediatric conditions, such as acute leukemia and organ transplant. 19 By comparison, the average rate of unplanned readmissions for all pediatric admissions is 6.5% at tertiary children's hospitals in the United States and at our institution. 19 The present pilot study was not powered to impact program-wide readmission rates. When compared with the web-video series, further study is needed to support this standardized HPN discharge process for reducing hospital readmissions.
Parent and staff feedback informed our project design. Upon discharge, families are expected to rapidly develop into expert healthcare providers. The majority of participants in our study had home nursing in place upon discharge, which can provide critical support. Families typically are the key caregivers responsible for CVC care and must maintain the highest care standards. We anticipated that the intervention would improve the familiarity of families with using home equipment and supplies. Families are often expected to provide other complex care at home such as EN care, which can also be burdensome. Parents in both groups reported a high degree of readiness for discharge, which were similar to what has been reported in bone marrow transplant parents. 20 The decision by the primary inpatient service to discharge imminently may heighten a family's perceptions on their readiness. In this cohort, we did not observe a correlation between readiness scores and postdischarge outcomes. The readiness variability among families with differing SBS diagnoses may reflect differences in discharge needs outside the purview of HPN, including other morbidities of SBS, such as associated congenital anomalies, small bowel bacterial overgrowth, and enteral tubes. Parents in both groups reported high scores for the quality of discharge teaching, making it challenging to demonstrate improvement in satisfaction. Families were pleased with both the content and delivery of the HPN teaching provided. For this population, there may be a steep learning curve faced when applying skills at home. High-fidelity simulation might better improve competence in CVC care and decrease complications, as has been seen with nurses in oncology and intensive care units. 21, 22 As the average LOS for this cohort was slightly >80 days, there would seem to be ample time for discharge teaching. However, the HPN team is necessarily involved throughout the entire course of the hospitalization. We only collected the number of formal HPN teaching sessions, not the time course of teaching. A notable finding of this study was that there was a 16% increase odds of readmission for each additional week of hospitalization associated with HPN discharge. Prolonged LOS is presumably a surrogate for medical and social complexities that are not apparent with collected variables. Future studies should build models to risk adjustment for HPN populations. Variation in readiness scores by ethnicity concurs with the literature showing racial disparities in outcomes in this population. 23, 24 Future studies should evaluate whether outcome differences are due to implicit bias or other factors.
There were limitations to the present study. First, it is impossible to control completely for variation of clinical care at home. It is difficult to evaluate how teaching parents prior to discharge affects healthcare behaviors of the entire household outside the hospital. For example, home care nurses rarely receive formal instruction at the hospital. In the present study, the vast majority of families received home nursing, but we unfortunately did not collect information on what type of care home nurses performed. Future studies might evaluate the role home nursing plays in postdischarge outcomes. Another limitation was that our team instituted multiple interventions simulateously during this 3-year study. For example, our team offered all families a predischarge briefing based on work done by the Agency for Healthcare Research and Quality. 25 Another limitation to generalizability was that many patients used an investigational lipid emulsion Omegaven (Fresenius Kabi AG, Bad Homburg vdh, Germany). Omegaven requires specific administration techniques as it is dispensed in 100 ml bottles and is not available as a total nutrient admixture, thus requiring the use of an additional infusion pump and a different administration set with a vented spike. 26 A final limitation is that it is difficult to control for all non-HPN factors that contribute to postdischarge adverse events such as readmission.
A strength of this study was the fairly homogenous study HPN population, including only SBS patients, reducing variability from the other HPN indications such as motility disorders, congenital diarrhea, or graft-vs-host disease. The patients' residual bowel length also closely matched what has been reported by the Pediatric Intestinal Failure Consortium. 27 Another strength was having a well-defined standardized discharge process and a single-expert HPN team responsible for discharge teaching. We also tracked discharge outcomes in a well-defined fashion. Future studies should study quality benchmarks across HPN programs, including family satisfaction scores and readmissions rates.
Conclusion
In this cohort with pediatric SBS, 30-day postdischarge readmission on HPN was more common than the most complex pediatric conditions despite extensive discharge teaching currently in place. Prolonged hospitalization was associated with higher rates of readmissions and ED visits. With refinement of HPN discharge process interventions, quality benchmarks are needed to compare outcomes across centers.
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